Organization
Xijing Hospital of Digestive Diseases
19 clinical trials
Clinical trial
Evaluation of Brain Connectivity Function in Predicting Therapeutic Effects in Patients With Refractory Constipation: a Multicenter, Prospective, Cohort StudyStatus: Recruiting, Estimated PCD: 2025-09-01
Clinical trial
Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal MicroecologyStatus: Recruiting, Estimated PCD: 2023-12-02
Clinical trial
Standard or Short-course Vonoprazan Non-bismuth Triple Therapy or High-dose Dual Therapy Versus Rabeprazole-bismuth Quadruple Therapy for Primary Helicobacter Pylori Eradication: A Single-center, Randomised, Controlled Trial.Status: Recruiting, Estimated PCD: 2024-06-25
Clinical trial
High-concentration Small-volume Versus Low-concentration Large-volume Iodine Solution for Esophageal Chromoendoscopy: a Multicenter, Randomized Equivalence TrialStatus: Recruiting, Estimated PCD: 2024-04-30
Clinical trial
Metformin Efficacy and Safety for Gastric Intestinal Metaplasia: a Randomized Controlled TrialStatus: Completed, Estimated PCD: 2023-05-31
Clinical trial
An Open Label Long-Term Study to Evaluate the Safety and Effectiveness of Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)Status: Recruiting, Estimated PCD: 2027-04-01
Clinical trial
Effect of Oral Helicobacter Pylori Infection on the Efficacy of Gastroluminal Helicobacter Pylori Eradication TherapyStatus: Recruiting, Estimated PCD: 2023-09-01
Clinical trial
Safety And Efficacy Study of Autologous Platelet-rich Plasma (PRP) and Thrombin Coagulum for the Topical Treatment of Rectal Mucosal UlcersStatus: Not yet recruiting, Estimated PCD: 2025-06-30
Clinical trial
A Prospective, Multi-center, Randomized, Double-blind, Placebo-controlled Study: Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis and an Inadequate Response to Ursodeoxycholic AcidStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis: a Randomized Control StudyStatus: Completed, Estimated PCD: 2022-05-06
Clinical trial
The Efficacy of N-acetylcysteine on Alleviating Symptom Caused by Lugol Chromoendoscopy: a Prospective, Non-inferiority, Randomized Controlled TrialStatus: Completed, Estimated PCD: 2021-04-30
Clinical trial
A Real World Study of Bismuth Colloidal Pectin Granules Quadruple Therapy for H. Pylori EradicationStatus: Completed, Estimated PCD: 2021-12-30
Clinical trial
Rescue Therapy for Helicobacter Pylori Eradication: A Randomized and Non-inferiority Trail of High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple TherapyStatus: Completed, Estimated PCD: 2021-12-20
Clinical trial
Efficacy and Safety of Berberine Hydrochloride, Amoxicillin and Rabeprazole Triple Therapy in the First Eradication of Helicobacter PyloriStatus: Completed, Estimated PCD: 2021-12-20
Clinical trial
Study on The Efficacy and Safety of Berberine,Amoxicillin and Vonoprazan Containing Triple Therapy in Helicobacter Pylori First-Line EradicationStatus: Completed, Estimated PCD: 2022-03-31
Clinical trial
The Efficacy of Topically Applied Mesalazine Sustained-Release Tablets in Oral Lesions of Crohn's DiseaseStatus: Withdrawn, Estimated PCD: 2016-12-01
Clinical trial
Fenofibrate Combined With Ursodeoxycholic Acid in Compensated Cirrhosis Patients With Primary Biliary Cholangitis Who Had an Inadequate Response to Ursodeoxycholic AcidStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
The Clinical Efficacy and Safety of Trimebutine Maleate Combined With Rabeprazole in Patients With Grade A or B Reflux Esophagitis Whose Symptoms Refractory to RabeprazoleStatus: Withdrawn, Estimated PCD: 2017-10-01
Clinical trial
Efficacy of Treatment With Berberine to Maintain Remission in Ulcerative Colitis: An Open-label,Randomized,Phase IV Clinical TrialStatus: Withdrawn, Estimated PCD: 2018-01-01